 Since the genome of the gutless virus does not include genes encoding the enzymes and/or structural proteins required to replicate, it is deemed safe for use in gene therapy since an infection cannot occur except in the presence of a suitable helper virus.Well established protocols allow scientists to propagate helper dependent viruses in the lab.However, using an actual helper virus poses problems when it comes to purification of a desired transgenic virus.